Mainland Chinese drug effective in treating 3 cancer types: Hong Kong-led study
A new drug developed by a mainland Chinese biotechnology company is effective in combating three types of cancer that currently have limited treatment options, a multinational study led by the Chinese University of Hong Kong (CUHK) has found. University researchers said on Monday that the novel drug, D3S-001, had shown “promising” results for treating non-small-cell…